Overview: Lithium TestIntroduction: The Lithium Test measures lithium levels to monitor bipolar disorder treatment, preventing mood swings. Following 2023 APA guidelines, it uses biochemical methods for high specificity, supporting drug monitoring. This test is critical for guiding treatment adjustments, ensuring therapeutic levels, and improving outcomes in biochemistry for patients with bipolar disorder.
Other Names: Lithium Assay, Bipolar Drug Level Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Lithium testing began in the 1950s with bipolar disorder research. Biochemical methods improved in the 2000s, enhancing precision.
Purpose: Measures lithium levels to monitor bipolar disorder treatment, guides dosing, and prevents mood swings.
Test Parameters: 1. Lithium Level
Pretest Condition: No fasting required. Collect serum or plasma. Report history of mood swings, bipolar treatment, or medication adherence.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document mood swings, bipolar disorder treatment, or medication side effects. Include current medications, especially other mood stabilizers.
Consent: Written consent required, detailing the tests purpose, bipolar treatment implications, and risks of blood collection.
Procedural Considerations: Uses biochemical methods (e.g., ion-selective electrode) to measure lithium in serum or plasma. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for bipolar disorder management.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Drug interactions may alter levels.
Clinical Significance: Therapeutic lithium levels ensure mood stabilization, guiding dosing adjustments. Subtherapeutic or toxic levels require treatment modification.
Specialist Consultation: Consult a psychiatrist for result interpretation and treatment planning.
Additional Supporting Tests: Renal function tests, thyroid function tests, or ECG to monitor lithium therapy.
Test Limitations: Drug interactions may affect levels; clinical correlation is needed. Timing of sample collection impacts results.
References: APA Bipolar Disorder Guidelines, 2023; American Journal of Psychiatry, Goodwin FK, 2022.
